Naftzger J. Christopher
CIK 0001496194
General Counsel and Corp Sec
Filings
5
Latest Feb 19, 2025
Issuers covered
2
Showing
5 of 5
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -0.3% | -0.3% | -0.3% | -0.3% |
| 90 days | 1 | 0% | -4.5% | -4.5% | -4.5% | -4.5% |
| 180 days | 1 | 100% | +0.6% | +0.6% | +0.6% | +0.6% |
| 365 days | 1 | 0% | -15.5% | -15.5% | -15.5% | -15.5% |
Issuers
Companies where Naftzger J. Christopher has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 4 | Feb 19, 2025 |
| NBRV | Nabriva Therapeutics PLC | 1 | Feb 1, 2022 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|